China Recombinant Peptides Market Research Report 2018

February 2018 | 96 pages | ID: C94A89BCAC4QEN
QYResearch

Abstracts

The global Recombinant Peptides market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%.

This report studies the Recombinant Peptides development status and future trend in China, focuses on top players in China, also splits Recombinant Peptides by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include

• Sandoz Pharma
• Stada Arzneimittel
• Amgen
• Hospira
• Actavis
• Cipla Ltd.
• Wockhardt Ltd.
• Biocon Ltd.

Geographically, this report splits the China market into six regions,

• South China
• East China
• Southwest China
• Northeast China
• North China
• Central China
• Northwest China

On the basis of product, this report displays the sales volume (K MT), revenue (Million USD), product price (USD/MT), market share and growth rate of each type, primarily split into

• Glucagon
• Calcitonin
• Other

On the basis of the end users/application, this report covers

• Oncology
• Blood Disorders
• Infectious Diseases
• Autoimmune Diseases
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

China Recombinant Peptides Market Research Report 2017

1 RECOMBINANT PEPTIDES OVERVIEW

1.1 Product Overview and Scope of Recombinant Peptides
1.2 Classification of Recombinant Peptides by Product Category
  1.2.1 China Recombinant Peptides Sales (K MT) Comparison by Type (2012-2022)
  1.2.2 China Recombinant Peptides Sales (K MT) Market Share by Type in 2016
  1.2.3 Glucagon
  1.2.4 Calcitonin
  1.2.5 Other
1.3 China Recombinant Peptides Market by Application/End Users
  1.3.1 China Recombinant Peptides Sales (K MT) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Oncology
  1.3.3 Blood Disorders
  1.3.4 Infectious Diseases
  1.3.5 Autoimmune Diseases
  1.3.6 Other
1.4 China Recombinant Peptides Market by Region
  1.4.1 China Recombinant Peptides Market Size (Million USD) Comparison by Region (2012-2022)
  1.4.2 South China Recombinant Peptides Status and Prospect (2012-2022)
  1.4.3 East China Recombinant Peptides Status and Prospect (2012-2022)
  1.4.4 Southwest China Recombinant Peptides Status and Prospect (2012-2022)
  1.4.5 Northeast China Recombinant Peptides Status and Prospect (2012-2022)
  1.4.6 North China Recombinant Peptides Status and Prospect (2012-2022)
  1.4.7 Central China Recombinant Peptides Status and Prospect (2012-2022)
1.5 China Market Size (Sales and Revenue) of Recombinant Peptides (2012-2022)
  1.5.1 China Recombinant Peptides Sales (K MT) and Growth Rate (%)(2012-2022)
  1.5.2 China Recombinant Peptides Revenue (Million USD) and Growth Rate (%)(2012-2022)

2 CHINA RECOMBINANT PEPTIDES MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 China Recombinant Peptides Sales and Market Share of Key Players/Manufacturers (2012-2017)
2.2 China Recombinant Peptides Revenue and Share by Players/Manufacturers (2012-2017)
2.3 China Recombinant Peptides Average Price (USD/MT) by Players/Manufacturers (2012-2017)
2.4 China Recombinant Peptides Market Competitive Situation and Trends
  2.4.1 China Recombinant Peptides Market Concentration Rate
  2.4.2 China Recombinant Peptides Market Share of Top 3 and Top 5 Players/Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Recombinant Peptides Manufacturing Base Distribution, Sales Area, Product Types

3 CHINA RECOMBINANT PEPTIDES SALES AND REVENUE BY REGION (2012-2017)

3.1 China Recombinant Peptides Sales (K MT) and Market Share by Region (2012-2017)
3.2 China Recombinant Peptides Revenue (Million USD) and Market Share by Region (2012-2017)
3.3 China Recombinant Peptides Price (USD/MT) by Regions (2012-2017)

4 CHINA RECOMBINANT PEPTIDES SALES AND REVENUE BY TYPE/ PRODUCT CATEGORY (2012-2017)

4.1 China Recombinant Peptides Sales (K MT) and Market Share by Type/ Product Category (2012-2017)
4.2 China Recombinant Peptides Revenue (Million USD) and Market Share by Type (2012-2017)
4.3 China Recombinant Peptides Price (USD/MT) by Type (2012-2017)
4.4 China Recombinant Peptides Sales Growth Rate (%) by Type (2012-2017)

5 CHINA RECOMBINANT PEPTIDES SALES BY APPLICATION (2012-2017)

5.1 China Recombinant Peptides Sales (K MT) and Market Share by Application (2012-2017)
5.2 China Recombinant Peptides Sales Growth Rate (%) by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 CHINA RECOMBINANT PEPTIDES PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Sandoz Pharma
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Recombinant Peptides Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Sandoz Pharma Recombinant Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Stada Arzneimittel
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Recombinant Peptides Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Stada Arzneimittel Recombinant Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Amgen
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Recombinant Peptides Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Amgen Recombinant Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Hospira
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Recombinant Peptides Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Hospira Recombinant Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Actavis
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Recombinant Peptides Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Actavis Recombinant Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Cipla Ltd.
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Recombinant Peptides Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Cipla Ltd. Recombinant Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Wockhardt Ltd.
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Recombinant Peptides Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Wockhardt Ltd. Recombinant Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Biocon Ltd.
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Recombinant Peptides Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Biocon Ltd. Recombinant Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
  6.8.4 Main Business/Business Overview

7 RECOMBINANT PEPTIDES MANUFACTURING COST ANALYSIS

7.1 Recombinant Peptides Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Recombinant Peptides

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Recombinant Peptides Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Recombinant Peptides Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 CHINA RECOMBINANT PEPTIDES MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

11.1 China Recombinant Peptides Sales (K MT), Revenue (Million USD) Forecast (2017-2022)
11.2 China Recombinant Peptides Sales (K MT) Forecast by Type (2017-2022)
11.3 China Recombinant Peptides Sales (K MT) Forecast by Application (2017-2022)
11.4 China Recombinant Peptides Sales (K MT) Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 METHODOLOGY AND DATA SOURCE

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

The report requires updating with new data and is sent in 2-3 business days after order is placed.


List of Tables and Figures

Figure Global and China Market Size (Million USD) Comparison (2012-2022)
Table Recombinant Peptides Sales (K MT) and Revenue (Million USD) Market Split by Product Type
Table Recombinant Peptides Sales (K MT) by Application (2016-2022)
Figure Product Picture of Recombinant Peptides
Table China Recombinant Peptides Sales (K MT) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)
Figure China Recombinant Peptides Sales Volume Market Share by Types in 2016
Figure Glucagon Product Picture
Figure Calcitonin Product Picture
Figure Other Product Picture
Figure China Recombinant Peptides Sales (K MT) Comparison by Application (2012-2022)
Figure China Sales Market Share (%) of Recombinant Peptides by Application in 2016
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Blood Disorders Examples
Table Key Downstream Customer in Blood Disorders
Figure Infectious Diseases Examples
Table Key Downstream Customer in Infectious Diseases
Figure Autoimmune Diseases Examples
Table Key Downstream Customer in Autoimmune Diseases
Figure Other Examples
Table Key Downstream Customer in Other
Figure South China Recombinant Peptides Revenue (Million USD) and Growth Rate (2012-2022)
Figure East China Recombinant Peptides Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest China Recombinant Peptides Revenue (Million USD) and Growth Rate (2012-2022)
Figure Northeast China Recombinant Peptides Revenue (Million USD) and Growth Rate (2012-2022)
Figure North China Recombinant Peptides Revenue (Million USD) and Growth Rate (2012-2022)
Figure Central China Recombinant Peptides Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Recombinant Peptides Sales (K MT) and Growth Rate (%)(2012-2022)
Figure China Recombinant Peptides Revenue (Million USD) and Growth Rate (%)(2012-2022)
Table China Recombinant Peptides Sales of Key Players/Manufacturers (2012-2017)
Table China Recombinant Peptides Sales Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Recombinant Peptides Sales Share (%) by Players/Manufacturers
Figure 2017 China Recombinant Peptides Sales Share (%) by Players/Manufacturers
Table China Recombinant Peptides Revenue by Players/Manufacturers (2012-2017)
Table China Recombinant Peptides Revenue Market Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Recombinant Peptides Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Recombinant Peptides Revenue Market Share (%) by Players/Manufacturers
Table China Market Recombinant Peptides Average Price of Key Players/Manufacturers (2012-2017)
Figure China Market Recombinant Peptides Average Price of Key Players/Manufacturers in 2016
Figure China Recombinant Peptides Market Share of Top 3 Players/Manufacturers
Figure China Recombinant Peptides Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Recombinant Peptides Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Recombinant Peptides Product Category
Table China Recombinant Peptides Sales (K MT) by Regions (2012-2017)
Table China Recombinant Peptides Sales Share (%) by Regions (2012-2017)
Figure China Recombinant Peptides Sales Share (%) by Regions (2012-2017)
Figure China Recombinant Peptides Sales Market Share (%) by Regions in 2016
Table China Recombinant Peptides Revenue (Million USD) and Market Share by Regions (2012-2017)
Table China Recombinant Peptides Revenue Market Share (%) by Regions (2012-2017)
Figure China Recombinant Peptides Revenue Market Share (%) by Regions (2012-2017)
Figure China Recombinant Peptides Revenue Market Share (%) by Regions in 2016
Table China Recombinant Peptides Price (USD/MT) by Regions (2012-2017)
Table China Recombinant Peptides Sales (K MT) by Type (2012-2017)
Table China Recombinant Peptides Sales Share (%) by Type (2012-2017)
Figure China Recombinant Peptides Sales Share (%) by Type (2012-2017)
Figure China Recombinant Peptides Sales Market Share (%) by Type in 2016
Table China Recombinant Peptides Revenue (Million USD) and Market Share by Type (2012-2017)
Table China Recombinant Peptides Revenue Market Share (%) by Type (2012-2017)
Figure Revenue Market Share of Recombinant Peptides by Type (2012-2017)
Figure Revenue Market Share of Recombinant Peptides by Type in 2016
Table China Recombinant Peptides Price (USD/MT) by Types (2012-2017)
Figure China Recombinant Peptides Sales Growth Rate (%) by Type (2012-2017)
Table China Recombinant Peptides Sales (K MT) by Applications (2012-2017)
Table China Recombinant Peptides Sales Market Share (%) by Applications (2012-2017)
Figure China Recombinant Peptides Sales Market Share (%) by Application (2012-2017)
Figure China Recombinant Peptides Sales Market Share (%) by Application in 2016
Table China Recombinant Peptides Sales Growth Rate (%) by Application (2012-2017)
Figure China Recombinant Peptides Sales Growth Rate (%) by Application (2012-2017)
Table Sandoz Pharma Recombinant Peptides Basic Information List
Table Sandoz Pharma Recombinant Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
Figure Sandoz Pharma Recombinant Peptides Sales (K MT) and Growth Rate (%)(2012-2017)
Figure Sandoz Pharma Recombinant Peptides Sales Market Share (%) in China (2012-2017)
Figure Sandoz Pharma Recombinant Peptides Revenue Market Share (%) in China (2012-2017)
Table Stada Arzneimittel Recombinant Peptides Basic Information List
Table Stada Arzneimittel Recombinant Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
Figure Stada Arzneimittel Recombinant Peptides Sales (K MT) and Growth Rate (%)(2012-2017)
Figure Stada Arzneimittel Recombinant Peptides Sales Market Share (%) in China (2012-2017)
Figure Stada Arzneimittel Recombinant Peptides Revenue Market Share (%) in China (2012-2017)
Table Amgen Recombinant Peptides Basic Information List
Table Amgen Recombinant Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
Figure Amgen Recombinant Peptides Sales (K MT) and Growth Rate (%)(2012-2017)
Figure Amgen Recombinant Peptides Sales Market Share (%) in China (2012-2017)
Figure Amgen Recombinant Peptides Revenue Market Share (%) in China (2012-2017)
Table Hospira Recombinant Peptides Basic Information List
Table Hospira Recombinant Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
Figure Hospira Recombinant Peptides Sales (K MT) and Growth Rate (%)(2012-2017)
Figure Hospira Recombinant Peptides Sales Market Share (%) in China (2012-2017)
Figure Hospira Recombinant Peptides Revenue Market Share (%) in China (2012-2017)
Table Actavis Recombinant Peptides Basic Information List
Table Actavis Recombinant Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
Figure Actavis Recombinant Peptides Sales (K MT) and Growth Rate (%)(2012-2017)
Figure Actavis Recombinant Peptides Sales Market Share (%) in China (2012-2017)
Figure Actavis Recombinant Peptides Revenue Market Share (%) in China (2012-2017)
Table Cipla Ltd. Recombinant Peptides Basic Information List
Table Cipla Ltd. Recombinant Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
Figure Cipla Ltd. Recombinant Peptides Sales (K MT) and Growth Rate (%)(2012-2017)
Figure Cipla Ltd. Recombinant Peptides Sales Market Share (%) in China (2012-2017)
Figure Cipla Ltd. Recombinant Peptides Revenue Market Share (%) in China (2012-2017)
Table Wockhardt Ltd. Recombinant Peptides Basic Information List
Table Wockhardt Ltd. Recombinant Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
Figure Wockhardt Ltd. Recombinant Peptides Sales (K MT) and Growth Rate (%)(2012-2017)
Figure Wockhardt Ltd. Recombinant Peptides Sales Market Share (%) in China (2012-2017)
Figure Wockhardt Ltd. Recombinant Peptides Revenue Market Share (%) in China (2012-2017)
Table Biocon Ltd. Recombinant Peptides Basic Information List
Table Biocon Ltd. Recombinant Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
Figure Biocon Ltd. Recombinant Peptides Sales (K MT) and Growth Rate (%)(2012-2017)
Figure Biocon Ltd. Recombinant Peptides Sales Market Share (%) in China (2012-2017)
Figure Biocon Ltd. Recombinant Peptides Revenue Market Share (%) in China (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant Peptides
Figure Manufacturing Process Analysis of Recombinant Peptides
Figure Recombinant Peptides Industrial Chain Analysis
Table Raw Materials Sources of Recombinant Peptides Major Players/Manufacturers in 2016
Table Major Buyers of Recombinant Peptides
Table Distributors/Traders List
Figure China Recombinant Peptides Sales (K MT) and Growth Rate (%) Forecast (2017-2022)
Figure China Recombinant Peptides Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Recombinant Peptides Price (USD/MT) Trend Forecast (2017-2022)
Table China Recombinant Peptides Sales (K MT) Forecast by Type (2017-2022)
Figure China Recombinant Peptides Sales (K MT) Forecast by Type (2017-2022)
Figure China Recombinant Peptides Sales Volume Market Share Forecast by Type in 2022
Table China Recombinant Peptides Sales (K MT) Forecast by Application (2017-2022)
Figure China Recombinant Peptides Sales Volume Market Share Forecast by Application (2017-2022)
Figure China Recombinant Peptides Sales Volume Market Share Forecast by Application in 2022
Table China Recombinant Peptides Sales (K MT) Forecast by Regions (2017-2022)
Table China Recombinant Peptides Sales Volume Share Forecast by Regions (2017-2022)
Figure China Recombinant Peptides Sales Volume Share Forecast by Regions (2017-2022)
Figure China Recombinant Peptides Sales Volume Share Forecast by Regions in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources